GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IOVA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Iovance Biotherapeutics, Inc. stock after losing 0.678%
(Updated on Apr 18, 2024)

Sell candidate since Apr 09, 2024 Loss -11.35% PDF

The Iovance Biotherapeutics, Inc. stock price fell by -0.678% on the last day (Thursday, 18th Apr 2024) from $11.80 to $11.72. During the last trading day the stock fluctuated 3.75% from a day low at $11.48 to a day high of $11.91. The price has fallen in 7 of the last 10 days and is down by -13.82% for this period. Volume has increased on the last day by 515 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 4 million shares were bought and sold for approximately $41.79 million.

Given the current short-term trend, the stock is expected to rise 43.14% during the next 3 months and, with a 90% probability hold a price between $16.78 and $30.31 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IOVA Signals & Forecast

There are few to no technical positive signals at the moment. The Iovance Biotherapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $12.21 and $14.28. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -32.91%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Iovance Biotherapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $9.95 and $9.18. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Iovance Biotherapeutics, Inc. finds support just below today's level at $9.95. If this is broken, then the next support from accumulated volume will be at $9.18 and $9.15.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.430 between high and low, or 3.75%. For the last week, the stock has had daily average volatility of 5.67%.

Iovance Biotherapeutics, Inc. is oversold on RSI14 (20). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IOVA) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Iovance Biotherapeutics, Inc. to open at $11.70, and during the day (based on 14 day Average True Range), to move between $10.89 and $12.55, which gives a possible trading interval of +/-$0.83 (+/-7.10%) up or down from last closing price. If Iovance Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 14.20% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $12.03 (2.65%) than the support at $9.95 (15.10%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Iovance Biotherapeutics, Inc. stock A Buy?

The Iovance Biotherapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Iovance Biotherapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.431 Sell Candidate Unchanged

Predicted Opening Price for Iovance Biotherapeutics, Inc. of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$11.70 ( 0.171%) $11.72

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IOVA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 12.13 3.50 %
R2 11.97 2.10 %
R1 11.86 1.23 %
Current price: 11.72
Support S1 11.54 -1.57 %
S2 11.43 -2.44 %
S3 11.27 -3.84 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 14.21 21.25 %
R2 13.91 18.69 %
R1 12.03 2.65 %
Current price 11.72
Support S1 9.95 -15.10%
S2 9.18 -21.67%
S3 9.15 -21.93%

FAQ

What is the symbol for Iovance Biotherapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Iovance Biotherapeutics, Inc. is IOVA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Iovance Biotherapeutics, Inc. Stock?
The Iovance Biotherapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Iovance Biotherapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Iovance Biotherapeutics, Inc. Stock?
Iovance Biotherapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Iovance Biotherapeutics, Inc. Stock.

What's the current price of Iovance Biotherapeutics, Inc. Stock?
As of the end of day on the 2024-04-18, the price of an Iovance Biotherapeutics, Inc. (IOVA) share was $11.72.

What is the 52-week high and low for Iovance Biotherapeutics, Inc. Stock?
The 52-week high for Iovance Biotherapeutics, Inc. Stock is $18.33 and the 52-week low is $3.21.

What is the market capitalization of Iovance Biotherapeutics, Inc. Stock?
As of the 2024-04-18, the market capitalization of Iovance Biotherapeutics, Inc. is 3.273B.

When is the next earnings date for Iovance Biotherapeutics, Inc.?
The upcoming earnings date for Iovance Biotherapeutics, Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics. Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers... IOVA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT